Dovramilast
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dovramilast, covering 2025-12-23 to 2025-12-23. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction [Phase 2]